CORT vs CUBE · P/E 199, rev $675.0M vs P/E 25, rev $1.07B
Corcept Therapeutics Incorporated (CORT) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported CORT revenue for 2024-12-31 was $675.0M. Net income was $141.2M. Revenue was up 39.9% from 2023-12-31 to 2024-12-31. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
CORT currently screens at market cap $7.46B and trailing P/E 198.5. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the CORT and CUBE stock pages for the full models.
Not investment advice.